See more : Kukje Pharma Co., Ltd. (002720.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Eckert & Ziegler Strahlen- und Medizintechnik AG, a leading company in the industry within the sector.
- Aprea Therapeutics, Inc. (APRE) Income Statement Analysis – Financial Results
- Danakali Limited (DNK.L) Income Statement Analysis – Financial Results
- Adhera Therapeutics, Inc. (ATRX) Income Statement Analysis – Financial Results
- ReNu Energy Limited (RNE.AX) Income Statement Analysis – Financial Results
- Liberty Gold Corp. (LGDTF) Income Statement Analysis – Financial Results
Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L)
About Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 246.09M | 222.26M | 180.44M | 176.14M | 178.49M | 168.71M | 138.63M | 137.94M | 140.05M | 127.26M | 117.14M | 120.00M | 116.20M | 111.09M | 101.40M | 71.61M | 0.00 | 0.00 | 41.79M | 35.53M | 29.20M | 31.22M |
Cost of Revenue | 129.75M | 115.48M | 89.36M | 89.61M | 91.47M | 94.36M | 74.77M | 71.81M | 77.70M | 63.47M | 60.06M | 54.81M | 51.79M | 53.30M | 50.28M | 37.45M | -25.95M | -23.90M | 23.30M | 19.23M | 15.75M | 15.96M |
Gross Profit | 116.34M | 106.78M | 91.08M | 86.53M | 87.02M | 74.35M | 63.87M | 66.12M | 62.35M | 63.78M | 57.08M | 65.18M | 64.41M | 57.80M | 51.12M | 34.16M | 25.95M | 23.90M | 18.49M | 16.31M | 13.46M | 15.27M |
Gross Profit Ratio | 47.28% | 48.04% | 50.48% | 49.13% | 48.75% | 44.07% | 46.07% | 47.94% | 44.52% | 50.12% | 48.72% | 54.32% | 55.43% | 52.03% | 50.42% | 47.70% | 0.00% | 0.00% | 44.25% | 45.89% | 46.08% | 48.90% |
Research & Development | 4.33M | 4.29M | 3.78M | 3.75M | 3.75M | 3.81M | 3.32M | 2.70M | 3.65M | 3.62M | 4.87M | 3.45M | 3.00M | 2.89M | 2.50M | 3.11M | -134.00K | -215.00K | 512.00K | 350.00K | 2.16M | 3.43M |
General & Administrative | 13.97M | 12.90M | 10.57M | 8.60M | 8.99M | 7.73M | 7.31M | 8.95M | 8.68M | 8.08M | 8.03M | 7.82M | 19.22M | 18.83M | 19.08M | 14.61M | 0.00 | 0.00 | 8.73M | 7.07M | 6.27M | 7.92M |
Selling & Marketing | 10.78M | 9.66M | 10.03M | 9.46M | 11.61M | 11.64M | 10.19M | 11.18M | 13.08M | 11.55M | 10.50M | 10.44M | 19.53M | 18.93M | 18.43M | 15.12M | -9.60M | -8.06M | 7.51M | 5.46M | 3.03M | 3.35M |
SG&A | 24.76M | 22.56M | 20.60M | 18.06M | 20.60M | 19.37M | 17.50M | 20.13M | 21.76M | 19.63M | 18.53M | 18.27M | 38.75M | 37.76M | 37.51M | 29.72M | -9.60M | -8.06M | 16.24M | 12.52M | 9.30M | 11.27M |
Other Expenses | 40.26M | 36.28M | 32.47M | 28.02M | 29.17M | 1.86M | 1.08M | 30.60M | 24.32M | 31.88M | 23.02M | 23.63M | -185.00K | -1.40M | -4.34M | -8.26M | 0.00 | 0.00 | -793.00K | -13.00K | -207.00K | -1.42M |
Operating Expenses | 70.89M | 63.13M | 56.86M | 49.83M | 53.52M | 52.91M | 46.48M | 50.73M | 46.08M | 51.51M | 46.41M | 45.35M | 41.57M | 39.48M | 35.66M | 24.57M | -9.74M | -8.27M | 15.96M | 12.86M | 11.26M | 13.27M |
Cost & Expenses | 199.10M | 178.60M | 146.21M | 139.43M | 144.99M | 147.27M | 121.25M | 122.54M | 123.78M | 114.98M | 106.48M | 100.17M | 93.35M | 92.77M | 85.94M | 62.02M | -35.69M | -32.17M | 39.26M | 32.08M | 27.01M | 29.23M |
Interest Income | 846.00K | 234.00K | 132.00K | 249.00K | 287.00K | 171.00K | 252.00K | 445.00K | 165.00K | 468.00K | 1.31M | 526.00K | 220.00K | 299.00K | 68.00K | 73.00K | 63.00K | 0.00 | 49.00K | 86.00K | 0.00 | 0.00 |
Interest Expense | 3.99M | 1.77M | 1.20M | 1.19M | 1.10M | 672.00K | 881.00K | 1.39M | 1.47M | 1.63M | 1.19M | 2.79M | 2.89M | 2.52M | 1.33M | 1.24M | 830.00K | 0.00 | 716.00K | 359.00K | 0.00 | 0.00 |
Depreciation & Amortization | 13.37M | 10.39M | 9.55M | 10.68M | 11.08M | 8.44M | 8.27M | 7.10M | 8.76M | 7.14M | 9.25M | 7.75M | 7.51M | 9.84M | 11.53M | 9.15M | 3.73M | 4.60M | 3.91M | 3.74M | 3.69M | 4.26M |
EBITDA | 59.67M | 56.70M | 56.68M | 42.31M | 42.93M | 31.95M | 26.50M | 23.68M | 27.15M | 20.83M | 20.54M | 26.26M | 29.42M | 25.41M | 23.61M | 15.40M | 9.48M | 10.16M | 6.45M | 7.19M | 5.88M | 6.25M |
EBITDA Ratio | 24.25% | 25.63% | 26.36% | 26.32% | 25.38% | 19.11% | 18.86% | 18.42% | 18.65% | 16.13% | 17.53% | 23.25% | 26.22% | 24.01% | 26.68% | 26.10% | 0.00% | 0.00% | 15.43% | 20.24% | 20.14% | 20.03% |
Operating Income | 47.00M | 42.44M | 46.03M | 35.24M | 31.63M | 23.19M | 19.19M | 15.39M | 16.30M | 12.32M | 10.70M | 19.93M | 22.85M | 18.32M | 16.42M | 9.59M | 5.97M | 5.88M | 2.54M | 3.45M | 2.20M | 1.99M |
Operating Income Ratio | 19.10% | 19.09% | 25.51% | 20.01% | 17.72% | 13.74% | 13.84% | 11.16% | 11.64% | 9.68% | 9.14% | 16.61% | 19.66% | 16.49% | 16.19% | 13.39% | 0.00% | 0.00% | 6.07% | 9.71% | 7.52% | 6.38% |
Total Other Income/Expenses | -4.69M | -1.71M | 355.00K | -2.04M | -381.00K | 550.00K | -267.00K | 179.00K | -764.00K | -519.00K | -1.67M | -2.49M | -2.62M | -3.97M | -308.00K | -1.29M | -1.05M | 0.00 | -321.00K | 186.00K | -292.00K | -1.08M |
Income Before Tax | 42.31M | 43.00M | 46.39M | 32.75M | 31.25M | 22.89M | 17.34M | 15.29M | 15.50M | 11.80M | 12.94M | 17.46M | 20.23M | 14.35M | 15.16M | 8.30M | 0.00 | 0.00 | 2.22M | 3.64M | 1.87M | 915.00K |
Income Before Tax Ratio | 17.19% | 19.35% | 25.71% | 18.59% | 17.51% | 13.57% | 12.51% | 11.08% | 11.07% | 9.27% | 11.05% | 14.55% | 17.41% | 12.92% | 14.95% | 11.59% | 0.00% | 0.00% | 5.30% | 10.23% | 6.39% | 2.93% |
Income Tax Expense | 11.82M | 13.26M | 11.73M | 9.63M | 8.77M | 6.00M | 5.32M | 4.63M | 5.14M | 5.30M | 2.44M | 5.70M | 8.82M | 3.94M | -6.74M | 5.26M | 0.00 | 0.00 | 724.00K | 1.33M | 1.04M | 569.00K |
Net Income | 26.30M | 29.28M | 34.53M | 21.29M | 22.02M | 16.13M | 14.70M | 9.55M | 10.72M | 6.78M | 9.09M | 10.29M | 11.42M | 10.42M | 21.89M | 3.04M | 0.00 | 0.00 | 1.59M | 3.43M | -1.17M | 346.00K |
Net Income Ratio | 10.69% | 13.17% | 19.14% | 12.09% | 12.34% | 9.56% | 10.60% | 6.92% | 7.65% | 5.32% | 7.76% | 8.58% | 9.82% | 9.38% | 21.59% | 4.24% | 0.00% | 0.00% | 3.80% | 9.64% | -4.02% | 1.11% |
EPS | 1.26 | 1.41 | 1.67 | 1.03 | 1.07 | 0.78 | 0.70 | 0.45 | 0.51 | 0.32 | 0.43 | 0.49 | 0.50 | 0.45 | 0.88 | 0.36 | 0.00 | 0.00 | 0.13 | 0.27 | -0.10 | 0.03 |
EPS Diluted | 1.26 | 1.41 | 1.66 | 1.03 | 1.07 | 0.78 | 0.70 | 0.45 | 0.51 | 0.32 | 0.43 | 0.49 | 0.50 | 0.45 | 0.87 | 0.36 | 0.00 | 0.00 | 0.13 | 0.27 | -0.10 | 0.03 |
Weighted Avg Shares Out | 20.81M | 20.76M | 20.70M | 20.59M | 20.53M | 20.67M | 21.15M | 21.15M | 21.15M | 21.15M | 21.15M | 21.15M | 21.10M | 20.78M | 15.13M | 12.57M | 12.57M | 13.00M | 12.41M | 12.24M | 11.93M | 13.00M |
Weighted Avg Shares Out (Dil) | 20.82M | 20.80M | 20.75M | 20.64M | 20.53M | 20.67M | 21.15M | 21.15M | 21.15M | 21.15M | 21.15M | 21.15M | 21.10M | 20.83M | 15.22M | 12.63M | 12.68M | 13.00M | 12.54M | 12.32M | 11.94M | 13.00M |
Source: https://incomestatements.info
Category: Stock Reports